Molnupiravir

Molnupiravir (brand names include: Lagevrio, Molnulup, Molnutor, Cipmolnu, Molxvir, Molflu) is an antiviral medication authorized for the treatment of mild-to-moderate COVID-19.

Molnupiravir inhibits the replication of certain RNA viruses and was originally developed for influenza.

Molnupiravir causes errors to accumulate in the genetic code of the coronavirus, preventing the virus from replicating.

Molnupiravir comes in packs of 40 tables.

Conseils d’utilisation

Follow the directions for using this medicine provided by your doctor. Use your medicine exactly as directed.

Composants

Active ingredient: molnupiravir.